✦ LIBER ✦

Treatment of Primary Chronic Glomerulonephritis with Rehmannia Glutinosa Acteosides in Combination with the Angiotensin Receptor Blocker Irbesartan: A Randomized Controlled Trial

✍ Scribed by Qiu, HongYu; Fu, Ping; Fan, WenXing; Zuo, Chuan; Feng, Ping; Shi, Peng; Cao, Lina; Liu, Fang; Zhou, Li; Chen, Feng; Zhong, Hui; Gou, ZhongPing; Liang, YaPing; Shi, Mei

Book ID: 121319205
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 224 KB
Volume: 28
Category: Article
ISSN: 0951-418X
DOI: 10.1002/ptr.4973

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of the Combination of Angiotensin

Safety of the Combination of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Heart Failure: A Systematic Review and Meta Analysis of Randomized Controlled Trials

✍ Rachid Lakhdar; Mouaz H. Al-Mallah 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Safety and Tolerability of Angiotensin-C

Safety and Tolerability of Angiotensin-Converting Enzyme Inhibitor Versus the Combination of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker in Patients With Left Ventricular Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

✍ Rachid Lakhdar; Mouaz H. Al-Mallah; David E. Lanfear 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 257 KB

RIBBON-2: A Randomized, Double-Blind, Pl

RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer

✍ Datko, F.M.; Dickler, M.N. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 295 KB